Author:
Makeyev Yan,Muggia Franco,Rajan Arun,Giaccone Giuseppe,Furuta Takahisa,Rougier Philippe
Reference148 articles.
1. The Camptothecins: Unfolding Their Anticancer Potential. (2000) Proceedings of a conference. March 17–20, 2000, Arlington, Virginia, USA. Ann N Y Acad Sci 922: xi-xii, 1–363
2. Adachi S, Ogasawara T, Yamasaki N, Shibahara H, Kanazawa R, Tsuji Y, Takemura T, Koyama K (1999) A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma. Jpn J Clin Oncol 29(9): 434–437
3. Ajani JA, Baker J, Pisters PWT, Ho L, Mansfield PF, Feig BW, Charnsangavej C (2002) CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study. Cancer 94(3): 641–646
4. Alberts DS, Markman M, Muggia F, Ozols RF, Eldermire E, Bookman MA, Chen T, Curtin J, Hess LM, Liebes L, Young RC, Trimble E (2006) Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecologic Oncology 103(3): 783–792
5. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y (2000) Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60(24): 6921–6926
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献